RPL3 — Ribosomal Protein L3
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">rpl3</th>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate-High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">28S rRNA</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">RPL5</td>
<td>Protein interaction</td>
</tr>
<tr>
<td class="label">RPL11</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">eEF-1A</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">eEF-2</td>
<td>Factor binding</td>
</tr>
<tr>
<td class="label">RPL23</td>
<td>Ribosomal protein interaction</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Known Target</td>
</tr>
<tr>
<td class="label">Rapamycin</td>
<td>mTORC1</td>
</tr>
<tr>
<td class="label">ISRIB</td>
<td>eIF2α</td>
</tr>
<tr>
<td class="label">Ribavirin</td>
<td>eIF4E</td>
</tr>
<tr>
<td class="label">Gadolinium</td>
<td>Ribosome</td>
</tr>
<tr>
<td class="label">Organism</td>
<td>RPL3 Homolog</td>
</tr>
<tr>
<td class="label">S. cerevisiae</td>
<td>RPL3</td>
</tr>
<tr>
<td class="label">D. melanogaster</td>
<td>RpL3</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>rpl-3</td>
</tr>
<tr>
<td class="label">D. rerio</td>
<td>rpl3</td>
</tr>
<tr>
<td class="label">M. musculus</td>
<td>Rpl3</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
Gene Symbol: RPL3 (Ribosomal Protein L3)
Chromosomal Location: 22q12.1
NCBI Gene ID: 6122
UniProt ID: P35978
RPL3 encodes Ribosomal Protein L3, a fundamental component of the large (60S) ribosomal subunit. As one of approximately 47 ribosomal proteins in the eukaryotic 60S subunit, RPL3 plays essential roles in ribosome assembly, protein synthesis, and specifically the peptidyl transferase catalytic activity that underlies peptide bond formation. While traditionally viewed as a "housekeeping" protein essential for cell survival, emerging research reveals important neuron-specific functions and clear dysregulation in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). RPL3 has emerged as a critical player in synaptic protein synthesis, neuronal stress responses, and the regulation of disease-specific protein translation.
RPL3 is particularly notable for its position at the peptidyl transferase center (PTC) of the ribosome, where it directly contributes to the catalytic mechanism of peptide bond formation. This central role in protein synthesis makes RPL3 a key determinant of translational capacity in neurons, which have exceptionally high protein synthesis demands due to their complex morphology, synaptic plasticity requirements, and long axonal projections. The dysfunction of RPL3 in neurodegeneration thus represents a fundamental impairment of cellular proteostasis that cascades into multiple pathological pathways.
Gene and Protein Structure
Genomic Organization
The human RPL3 gene spans approximately 6.5 kb on chromosome 22q12.1 and consists of:
- 7 exons encoding the mature protein
- 5' UTR containing upstream open reading frames (uORFs) for translational regulation
- 3' UTR containing polyadenylation signals and regulatory elements including AU-rich elements (AREs)
Protein Structure
RPL3 is a 397-amino acid protein with a molecular weight of approximately 43.2 kDa. Key structural features include:
N-terminal domain: Contains the peptidyl transferase center (PTC) interaction interface
Central domain: Forms the core of the 60S subunit's GTPase-associated center
C-terminal domain: Interacts with ribosomal RNA and translation factorsThe protein contains:
- RNA-binding motifs: K-rich and R-rich regions for 28S rRNA interaction
- Helix-turn-helix domain: For nucleic acid binding
- GTPase interaction site: For interaction with elongation factors (eEF-1A, eEF-2)
Ribosomal Context
Within the 60S subunit, RPL3 is located:
- At the peptidyl transferase center (PTC)
- Near the factor-binding site
- Adjacent to the GTPase-associated center
- Interacting with the central protuberance (RPL5, RPL11)
Expression Pattern
Tissue Distribution
RPL3 is ubiquitously expressed across all tissues, with highest levels in:
- Brain: Particularly in neurons with high translational activity
- Liver: High metabolic and protein synthesis demand
- Kidney: Active protein synthesis
- Skeletal muscle: High protein turnover
- Testis: Active in spermatogenesis
Brain Regional Expression
Cell-Type Specificity
- Neurons: Very high expression, localized throughout soma, dendrites, and axons
- Astrocytes: Moderate expression
- Microglia: Lower expression, increases with activation
- Oligodendrocytes: Moderate expression, higher in myelinating oligodendrocytes
Role in Neurodegeneration
Alzheimer's Disease (AD)
Ribosomal dysfunction is a well-documented and early feature of AD pathogenesis, with RPL3 playing a central role:
Translational deficit: Significant reduction in global translation rates in AD brains correlates strongly with cognitive decline. RPL3 protein levels are consistently altered in vulnerable brain regions including the hippocampus and frontal cortex[@cheng2019].
Ribosome assembly defects: Impaired 60S subunit biogenesis leads to decreased translational capacity. RPL3 phosphorylation states are altered in AD[@liu2020].
Synaptic translation impairment: Synaptic dysfunction in AD involves specific deficits in the synaptic translation machinery. RPL3 in synaptosomes shows decreased activity and altered post-translational modifications[@yang2019].
Tau pathology relationship: Ribosomal dysfunction precedes tau aggregation in multiple model systems. RPL3 interacts with tau pathology markers[@ding2020].
Amyloid-beta (Aβ) effects: Aβ oligomers directly impair ribosomal function through:
- Binding to ribosomal proteins including RPL3
- Disrupting translation elongation
- Causing ribosomal subunit misassembly
- Reducing polysome stability[@zhang2019]
Parkinson's Disease (PD)
In PD, RPL3 dysregulation contributes to multiple aspects of pathogenesis:
Dopaminergic neuron vulnerability: Reduced translation capacity makes dopaminergic neurons in the substantia nigra particularly susceptible to cellular stress[@kim2019].
α-Synuclein translation: Altered ribosomal function affects α-synuclein synthesis rates, potentially creating a feed-forward pathological loop.
Mitochondrial stress response: RPL3 coordinates stress response translation, including mitochondrial protein synthesis during cellular stress[@liu2018].
Protein homeostasis failure: Impaired translation contributes to aggresome formation and proteostasis failure characteristic of PD.
Lewy body pathology: RPL3 alterations are observed in Lewy body diseases including PD and Dementia with Lewy Bodies (DLB)[@parkinson2021].Amyotrophic Lateral Sclerosis (ALS)
RPL3 in ALS pathogenesis:
Motor neuron-specific vulnerability: Motor neurons have extremely high translational demands, making them particularly sensitive to ribosomal alterations.
Stress granule formation: RPL3 is recruited to stress granules in ALS models, where it may regulate the translation of specific stress response mRNAs.
C9orf72 translation: Dysregulated translation of hexanucleotide repeat expansion transcripts involves ribosomal protein alterations.
RNA granule dynamics: RPL3 participates in RNA granule trafficking in neurons, with alterations in ALS.Frontotemporal Dementia (FTD)
- Translation dysregulation similar to ALS patterns
- RPL3 in stress granule pathology
- Connection to RNA-binding protein diseases including FTD-GRN
Molecular Mechanisms
Protein Synthesis Functions
RPL3 participates in several essential translation processes:
Peptidyl transferase activity: Central to the catalytic activity of the ribosome
Translation elongation: Part of the elongation factor complex
Ribosome recycling: Works with eEF-1A for subunit dissociation
Quality control: Monitors translational fidelityKey Interaction Partners
Translational Control Pathways
mRNA → 43S pre-initiation complex → 48S initiation complex
↓
60S subunit joining
↓
RPL3-PTC function
↓
Peptide bond formation
↓
Elongation → Termination
Stress Response Integration
RPL3 serves as an integrator of cellular stress responses:
Integrated stress response (ISR): Phosphorylation of eIF2α reduces global translation while selectively translating specific stress response mRNAs. RPL3 helps direct this selective translation[@wang2021].
Unfolded protein response (UPR): Ribosomal quality control initiates UPR signaling in ER stress, with RPL3 participating in translational attenuation.
Oxidative stress: Translation arrest protects against oxidative damage. RPL3 oxidation alters its function under oxidative conditions.
Nutrient deprivation: RPL3 modifications adapt translation to nutrient availability through mTOR signaling crosstalk.
DNA damage: Ribosomal proteins including RPL3 coordinate translation with DNA damage response pathways.Ribosomal Dysfunction in Neurodegeneration
The Ribosomopathy Concept
Ribosomal dysfunction has emerged as a key mechanism in neurodegeneration, with RPL3 at the crossroads:
Global Translation Deficits in AD/PD
- Reduced polysome abundance in AD and PD brains correlating with disease severity
- Decreased ribosomal RNA levels and ribosomal protein content
- Impaired ribosome assembly machinery
- Selective loss of specific ribosomal proteins including RPL3
Selective Translation Dysregulation
- Certain mRNAs more affected than others in neurodegeneration
- Synaptic transcripts particularly vulnerable to translational repression
- Disease-specific translation patterns affecting critical neuronal proteins
- RPL3 alterations affect specific mRNA translation
Ribosome Quality Control Failure
- Accumulation of stalled ribosomes in disease states
- Defective ribosome recycling
- Ribosome-associated quality control (RQC) pathway impairment
- Collision-induced translational repression
Therapeutic Implications
Targeting Ribosomal Dysfunction
Translation-enhancing compounds: Small molecules that enhance ribosomal function are being explored
mTOR modulators: Targeting upstream signaling to enhance translation
ISR modulators: Fine-tuning the integrated stress response
Ribosomal protein stabilization: Preventing RPL3 degradationBiomarker Potential
- RPL3 levels in cerebrospinal fluid (CSF) as a biomarker
- Post-translational modifications as disease state indicators
- RPL3 autoantibodies in neurodegenerative disease
Mermaid Diagram: RPL3 in Neurodegeneration
Mermaid diagram (expand to render)
Experimental Evidence
Human Studies
Post-mortem brain studies have consistently demonstrated RPL3 alterations in neurodegenerative diseases:
AD hippocampus: Reduced RPL3 protein levels correlating with cognitive decline scores[@cheng2019]
PD substantia nigra: Altered RPL3 expression in dopaminergic neurons[@kim2019]
ALS motor cortex: RPL3 recruitment to stress granules
FTD frontal cortex: Translation machinery alterationsAnimal Models
RPL3 knockout mice: Show impaired learning and memory with synaptic dysfunction[@yoshikawa2018]
RPL3 knockdown in zebrafish: Developmental neurological deficits
Conditional RPL3 deletion: Progressive neurodegeneration
RPL3 overexpression: Partial rescue of translational deficitsCell Culture Studies
Neuronal cultures: Aβ-induced RPL3 alterations
α-Synuclein models: RPL3 dysregulation
Oxidative stress: RPL3 oxidation and functional changes
Glutamate excitotoxicity: RPL3 involvement in stress responseMolecular Studies
Ribosome profiling: Altered translation of specific mRNAs
Polysome analysis: Reduced polysome association in disease
Protein-protein interactions: RPL3 interaction network changes
Post-translational modifications: Phosphorylation, oxidation statesSynaptic Function and Learning
Synaptic Ribosomes
RPL3 plays critical roles in synaptic function:
Local translation: Synaptic ribosomes regulate local protein synthesis at synapses
Synaptic plasticity: RPL3-dependent translation underlies long-term potentiation (LTP) and long-term depression (LTD)
Synapse maintenance: Proper ribosomal function maintains synaptic structure
Activity-dependent translation: Neuronal activity regulates RPL3 modificationsLearning and Memory
RPL3 is essential for learning and memory:
Memory consolidation: New protein synthesis required for consolidation
Synaptic scaling: Activity-dependent synaptic strengthening
Axon guidance: Translation regulation in growth cones
Dendritic spine morphology: Protein synthesis for spine remodelingTherapeutic Targeting
Small Molecule Approaches
Translation enhancers: Gentamicin, aminoglycosides for readthrough
mTOR inhibitors: Rapamycin for ISR modulation
eIF2α phosphatase inhibitors: ISRIB for integrated stress response
Ribosomal stabilizers: Compound screening for RPL3 interactionsGene Therapy Approaches
RPL3 overexpression: AAV-mediated gene delivery
RNAi knock-down: For gain-of-function mutations (rare)
CRISPR activation: Epigenetic upregulation
Antisense oligonucleotides: ASOs targeting RPL3 regulatory elementsRepurposing Candidates
Biomarker Potential
Cerebrospinal Fluid Biomarkers
- RPL3 levels in CSF correlate with disease progression
- RPL3 autoantibodies as diagnostic markers
- Post-translational modifications as stage indicators
- Comparison with established biomarkers (Aβ, tau, α-syn)
Blood-Based Biomarkers
- Peripheral blood mononuclear cell RPL3
- Exosomal RPL3
- Platelet RPL3 as surrogate
- Longitudinal tracking potential
Imaging Correlations
- RPL3 PET ligand development
- Correlation with FDG-PET hypometabolism
- Structural MRI atrophy patterns
Comparative Biology
Evolutionary Conservation
RPL3 is highly conserved across species:
- Yeast to human: ~88% identity
- Essential gene in all eukaryotes
- Neuron-specific functions acquired in vertebrates
Model Organisms
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/als)
- [Ribosomal Proteins](/entities/ribosomal-proteins)
- [Translation Machinery](/entities/translation-machinery)
- [Synaptic Plasticity](/entities/synaptic-plasticity)
- [Stress Granules](/entities/stress-granules)
- [Integrated Stress Response](/entities/integrated-stress-response)
- [Tau Pathology](/entities/tau-protein)
- [Alpha-Synuclein](/entities/alpha-synuclein)
External Links
- [NCBI Gene - RPL3](https://www.ncbi.nlm.nih.gov/gene/6122)
- [UniProt - RPL3](https://www.uniprot.org/uniprot/P35978)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=RPL3+neurodegeneration)
- [OMIM - RPL3](https://www.omim.org/entry/604377)
Brain Atlas Resources
- [Allen Human Brain Atlas - Gene Expression](https://human.brain-map.org/microarray/search/show?search_term=RPL3): Gene expression data
- [BrainSpan](https://www.brainspan.org/): Developmental expression
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/): Mouse expression data
- [Human Protein Atlas](https://www.proteinatlas.org/): Protein expression